Breaking News
Get 50% Off 0
🏄 Grow your portfolio even on vacation with InvestingPro | Summer Sale 50% OFF
CLAIM SALE
Close

Cohance Lifesciences Limited (COHA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
948.85 +7.30    +0.78%
06:59:28 - Real-time Data. Currency in INR
Type:  Equity
Market:  India
ISIN:  INE03QK01018 
S/N:  COHANCE
  • Volume: 32,417
  • Bid/Ask: 948.50 / 948.85
  • Day's Range: 935.45 - 951.80
Cohance Lifesciences 948.85 +7.30 +0.78%

Cohance Lifesciences Limited Company Profile

 
Get an in-depth profile of Cohance Lifesciences Limited, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

1193

Equity Type

ORD

Cohance Lifesciences Limited engage in the end-to-end contract development and manufacturing of intermediates and active pharmaceutical ingredients in India. The coampny offers active pharmaceutical ingredients and formulations for various applications; CDMO services, a flexible and custom solutions for challenging development and manufacturing needs; and clinical, analytical, and research services. It also manufactures finished dosage formulations for pharmaceutical companies; and specialty chemicals, such as electronic chemicals. The company was formerly known as Suven Pharmaceuticals Limited and changed its name to Cohance Lifesciences Limited in May 2025. The company was founded in 1989 and is based in Hyderabad, India. Cohance Lifesciences Limited is a subsidiary of Berhyanda Limited.

Contact Information

Address 202, B-Wing, Galaxy by Aurobindo Realty, Sy No 83/1 2nd Floor
Panmaktha Plot, 1, Hitech City Rd, opp. IKEA Hyderabad Knowledge City TSIIC Raidurg Hyderabad,500081
India
Phone 91 40 4475 8595
Fax 91 40 4475 8596

Top Executives

Name Age Since Title
Govinda Prasad Dasu 72 - Independent & Non-Executive Director
Venkateswarlu Jasti 76 2019 Member of Advisory Council
Vinod Padikkal - 2024 Non-Executive Director
William Downie 58 2025 Member of Advisory Council
Mark Peacock 64 2025 Member of Advisory Council
Pravin Udhyavara Bhadya Rao 64 2023 Independent Director
Pankaj Patwari 45 2023 Non-Executive Director
Stefan Stoffel 59 2023 Member of Advisory Council
Annaswamy Vaidheesh - 2023 Vice-Chairperson of Advisory Council
Matangi Gowrishankar 67 2023 Independent Director
Jai Shankar Krishnan - 2024 Independent Director
Vivek Sharma - 2024 Executive Chairman
Bhasker Iyer - 2025 Member of Advisory Council
Kumarapuram Gopalakrishnan Ananthakrishnan 68 2023 Independent Director
Shweta Jalan 49 2023 Non-Executive Director
Vinod Rao 62 2023 Independent Director
Abhijit Mukherjee 67 2023 Member of Advisory Council
Vetukuri Venkata Naga Kali Vara Prasada Raju - 2023 MD & Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

COHA Comments

Write your thoughts about Cohance Lifesciences Limited
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email